Coagulation abnormalities in patients with cyanotic congenital heart disease.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Cardiothoracic and Vascular Anesthesia

• Publication date

  2002-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/JCAN.2002.128436PMID 12486661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet producton and survival in cyanotic congenital heart disease.

  2009cited by this paper
• The Pharmacokinetics of ε-Aminocaproic Acid in Children Undergoing Surgical Repair of Congenital Heart Defects:

  2002cited by this paper
• The pharmacokinetics of epsilon-aminocaproic acid in children undergoing surgical repair of congenital heart defects.

  2002cited by this paper
• Anaphylactic Reactions to Aprotinin Reexposure in Cardiac Surgery: Relation to Antiaprotinin Immunoglobulin G and E Antibodies

  2001cited by this paper
• Aprotinin and the systemic inflammatory response after cardiopulmonary bypass.

  2001cited by this paper
• Haemostatic changes in children with cyanotic and acyanotic congenital heart disease.

  2000cited by this paper
• Hemostatic Parameters and Platelet Activation Marker Expression in Cyanotic and Acyanotic Pediatric Patients Undergoing Cardiac Surgery in the Presence of Tranexamic Acid

  2000cited by this paper
• The preceptor in pediatric residency programs: main attributes

  2000cited by this paper
• Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease.

  2000cited by this paper
• Epsilon aminocaproic acid in paediatric cardiac surgery to reduce postoperative blood loss.

  2000cited by this paper
• Is there a difference between right and left femoral bone density?

  2000cited by this paper
• Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study

  2000cited by this paper
• Efficacy of epsilon-aminocaproic acid in children undergoing cardiac surgery.

  1999cited by this paper
• Efficacy of ϵ-aminocaproic acid in children undergoing cardiac surgery

  1999cited by this paper
• Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit.

  1999cited by this paper
• Con: the routine use of aprotinin during pediatric cardiac surgery is not a benefit.

  1999cited by this paper
• Activation of hemostasis during cardiopulmonary bypass and pediatric aprotinin dosage.

  1998cited by this paper
• Cyanotic congenital heart disease : a multisystem disorder

  1998cited by this paper
• Use of modified ultrafiltration after repair of congenital heart defects.

  1998cited by this paper
• Aprotinin in pediatric cardiac operations: a benefit in complex malformations and with high-dose regimen only.

  1998cited by this paper
• Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations.

  1998cited by this paper
• Cardiac surgery for grown-up congenital heart patients: survey of 307 consecutive operations from 1991 to 1994.

  1997cited by this paper
• The haematological management of patients with cyanotic congenital heart disease. A time for consensus?

  1997cited by this paper
• epsilon-Aminocaproic Acid Plasma Levels During Cardiopulmonary Bypass

  1997cited by this paper
• [Open heart surgery without blood transfusion for complete atrioventricular septal defect associated with tetralogy of Fallot].

  1997cited by this paper
• Prospective, randomized, double-blind study of high-dose aprotinin in pediatric cardiac operations.

  1997cited by this paper
• The Efficacy of Tranexamic Acid Versus Placebo in Decreasing Blood Loss in Pediatric Patients Undergoing Repeat Cardiac Surgery

  1997cited by this paper
• The Effects of epsilon-Aminocaproic Acid on Fibrinolysis and Thrombin Generation During Cardiac Surgery

  1997cited by this paper
• 28th Annual Meeting of the Society for Obstetric Anesthesia and Perinatology

  1996cited by this paper
• High-volume, Zero-balanced Hemofiltration to Reduce Delayed Inflammatory Response to Cardiopulmonary Bypass in Children

  1996cited by this paper
• [Open heart surgery with bloodless priming for cyanotic congenital heart diseases--the role of autologous blood donation after induction of anesthesia].

  1996cited by this paper
• The Efficacy and Cost of Aprotinin in Children Undergoing Reoperative Open Heart Surgery

  1996cited by this paper
• [Aprotinin reduces homologous blood transfusions when pediatric cardiac surgery must be redone].

  1996cited by this paper
• Mediastinal bleeding after cardiopulmonary bypass in pediatric patients.

  1996cited by this paper
• The effect of preoperative tranexamic acid on blood loss after cardiac operations in children.

  1996cited by this paper
• Cerebrovascular events in adult patients with cyanotic congenital heart disease.

  1996cited by this paper
• Aprotinin in children undergoing repair of congenital heart defects.

  1995cited by this paper
• Aprotinin in children undergoing correction of congenital heart defects. A double-blind pilot study.

  1994cited by this paper
• Effects of pentoxifylline (trental) on blood flow, viscosity, and oxygen transport in young adults with inoperable cyanotic congenital heart disease

  1994cited by this paper
• Influence of aprotinin on the thrombomodulin/protein C system in pediatric cardiac operations.

  1994cited by this paper
• Renal effects of low dose aprotinin in pediatric cardiac surgery.

  1994cited by this paper
• Coagulation defects in neonates during cardiopulmonary bypass.

  1993cited by this paper
• Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations. Influence on platelet function and blood loss.

  1993cited by this paper
• Desmopressin does not decrease bleeding after cardiac operation in young children.

  1993cited by this paper
• Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations

  1993cited by this paper
• Hemostatic activation during cardiopulmonary bypass with different aprotinin dosages in pediatric patients having cardiac operations.

  1993cited by this paper
• Invited letter concerning: aprotinin use in pediatric cardiac operations.

  1993cited by this paper
• Blood conservation during pediatric cardiac surgery: ultrafiltration of the extracorporeal circuit volume after cardiopulmonary bypass.

  1993cited by this paper
• A clinico-hematological study of iron deficiency anemia and its correlation with hyperviscosity symptoms in cyanotic congenital heart disease.

  1993cited by this paper
• Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism.

  1993cited by this paper
• The effects of aprotinin on hemostatic function during cardiac surgery.

  1991cited by this paper
• Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children.

  1991cited by this paper
• The effect of aprotinin (trasylol) on postoperative bleeding in cyanotic congenital heart disease.

  1991cited by this paper
• Open heart surgery in children of Jehovah's witnesses: Extreme hemodilution on cardiopulmonary bypass

  1991cited by this paper
• Comparison of the hemostatic effects of fresh whole blood, stored whole blood, and components after open heart surgery in children

  1991cited by this paper
• Effect of tranexamic acid on platelet ADP during extracorporeal circulation

  1991cited by this paper
• Cyanotic congenital heart disease: hematologic management.

  1991cited by this paper
• Book reviews : Reid CC, Kurusz M, Lawrence AE: Safety and techniques in perfusion. Stafford, Texas: Quali- Med Inc. 264pp; 36 ill

  1990cited by this paper
• Aprotinin in paediatric cardiac surgery

  1990cited by this paper
• Transfusion of fresh whole blood stored (4 degrees C) for short period fails to improve platelet aggregation on extracellular matrix and clinical hemostasis after cardiopulmonary bypass.

  1990cited by this paper
• Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization.

  1990cited by this paper
• Adverse haemodynamic effects of high‐dose aprotinin in a paediatric cardiac surgical patient

  1990cited by this paper
• Determinants of hemoglobin concentration in cyanotic heart disease

  1990cited by this paper
• Aprotinin and thrombus formation on pulmonary artery catheters: a piece of the coagulation puzzle.

  1990cited by this paper
• Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.

  1990cited by this paper
• The effect of desmopressin acetate (DDAVP) on postoperative blood loss after cardiac operations in children.

  1989cited by this paper
• The hemostatic effect of transfusing fresh whole blood versus platelet concentrates after cardiac operations.

  1988cited by this paper
• Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials.

  1988cited by this paper
• Effect of iron deficiency on tissue oxygen delivery in cyanotic congenital heart disease.

  1988cited by this paper
• Changes in sufentanil pharmacokinetics within the neonatal period.

  1988cited by this paper
• Erythropoietin in cyanotic heart disease.

  1988cited by this paper
• Effect of aprotinin on need for blood transfusion after repeat open-heart surgery.

  1987cited by this paper
• Development of the human coagulation system in the full-term infant.

  1987cited by this paper
• Serum erythropoietin levels in patients with congenital heart disease.

  1987cited by this paper
• Preoperative evaluation of hemostasis in patients with congenital heart disease.

  1987cited by this paper
• Repeat median sternotomy in pediatrics: experience in 164 consecutive cases.

  1986cited by this paper
• Red blood cell disorders and stroke.

  1986cited by this paper
• Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial.

  1986cited by this paper
• Treatment with Desmopressin Acetate to Reduce Blood Loss after Cardiac Surgery

  1986cited by this paper
• Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease.

  1986cited by this paper
• Use of sufficient hemodilution to prevent coagulopathies following surgical correction of cyanotic heart disease.

  1985cited by this paper
• Hemodynamic effects of guanfacine in essential hypertension.

  1984cited by this paper
• Aprotinin in open-heart surgery of infants and children using the heart-lung machine.

  1984cited by this paper
• Cyanotic Congenital Heart Disease in Children: Hemostatic Disorders and Relevance of Molecular Markers of Hemostasis

  1984cited by this paper
• Total bloodless open heart surgery in the pediatric age group.

  1984cited by this paper
• Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia.

  1983cited by this paper
• Polycythemia: mechanisms and management.

  1981cited by this paper
• Iron deficiency in infancy and childhood.

  1980cited by this paper
• Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications.

  1980cited by this paper
• Clinical Pharmacokinetics in Newborns and Infants

  1980cited by this paper
• The Effect of Iron Deficiency on Whole Blood Viscosity in Polycythaemic Patients

  1979cited by this paper
• Haemostatic defects in cyanotic congenital heart disease.

  1979cited by this paper
• Increased blood viscosity in patients with cyanotic congenital heart disease and iron deficiency.

  1979cited by this paper
• Christopher George Attenborough.

  1979cited by this paper
• CEREBRAL BLOOD-FLOW IN POLYCYTHqMIA

  1977cited by this paper
• EFFECT OF HÆMATOCRIT ON CEREBRAL BLOOD-FLOW IN MAN

  1977cited by this paper
• Platelet Release Abnormality and Reduced Prothrombin Levels in Children with Cyanotic Congenital Heart Disease

  1977cited by this paper
• Impairment of platelet adhesiveness and platelet factor 3 activity in cyanotic congenital heart disease.

  1976cited by this paper
• Shortened platelet survival in cyanotic heart disease.

  1975cited by this paper
• Consumption coagulopathy in a child with congenital cyanotic heart disease and its treatment with heparin

  1975cited by this paper

• Successful pediatric heart transplantation with bivalirudin use in a cyanotic single ventricle patient with an intracorporeal continuous flow ventricular assist device and heparin-induced thrombocytopenia

  2025cites this paper
• Non-cardiac surgeries in adults with congenital heart disease -influence of complexity of disease and estimated risk of surgery on adverse events.

  2025cites this paper
• Late presenting tetralogy of Fallot—surgical management

  2025cites this paper
• The cell-based approach of hemostasis, coagulopathy, and the implications for the pediatric cardiac anesthesiologist

  2025cites this paper
• Prospective Interventional Cohort Study using AIIMS Simplified POC Algorithm for Restricted Blood Transfusion in Cyanotic Children

  2024cites this paper
• Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures

  2024cites this paper
• Postoperative bleeding outcome of fresh frozen plasma prime in pediatric cardiac surgery: A systematic review & meta-analysis

  2024influential citation
• Coagulation Profile in Neonates with Congenital Heart Disease: A Pilot Study

  2024influential citation
• Hematologic Derangements among Children with Unoperated Cyanotic Congenital Heart Disease in Ethiopia

  2023cites this paper
• Anaesthesia Perioperative Management in Laparotomy Procedure in Neonates with Tetralogy of Fallot (ToF): A Case Study

  2023cites this paper
• Epidemiology of severe bleeding in children following cardiac surgery involving cardiopulmonary bypass: use of Bleeding Assessment Scale for critically Ill Children (BASIC)

  2022cites this paper
• Comparison of thromboelastographic profiles in pediatric patients with congenital heart disease according to existence of cyanosis

  2022cites this paper
• Plasma and Platelet Transfusions Strategies in Neonates and Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass or Neonates and Children Supported by Extracorporeal Membrane Oxygenation: From the Transfusion and Anemia EXpertise Initiative–Control/Avoidance of Bleeding

  2022cites this paper
• Coagulation abnormalities in children with uncorrected congenital heart defects seen at a teaching hospital in a developing country

  2022cites this paper
• Tranexamic acid reduces postoperative blood loss in Chinese pediatric patients undergoing cardiac surgery

  2022cites this paper
• Bivalirudin anticoagulation in neonates and infants undergoing cardiac surgery.

  2022cites this paper
• JCS 2022 Guideline on Management and Re-Interventional Therapy in Patients With Congenital Heart Disease Long-Term After Initial Repair.

  2022cites this paper
• Iron deficiency and iron deficiency anaemia in children: physiology, epidemiology, aetiology, clinical effects, laboratory diagnosis and treatment: literature review

  2021cites this paper
• Paraganglioma in an adolescent awaiting a cardiac transplant due to unrepaired congenital cyanotic heart disease and a univentricular heart: the first reported case

  2021cites this paper
• Blood Conservation and Hemostasis Management in Pediatric Cardiac Surgery

  2021cites this paper
• Neurologic complications of pediatric congenital heart disease.

  2021cites this paper
• Anesthetic Concerns in Children with Brain Abscess and Congenital Heart Disease

  2021cites this paper
• Comparison of efficacy of two different doses of tranexamic acid in prevention of post operative blood loss in patients with congenital cyanotic heart disease undergoing cardiac surgery

  2021cites this paper
• Comparison of erythrocyte indices and haematological indices as markers of iron status of lagos children with cyanotic congenital heart disease

  2020cites this paper
• Association Between Cyanosis, Transfusion, and Thrombotic Complications in Neonates and Children Undergoing Cardiac Surgery.

  2020cites this paper
• Shunt thrombosis in pediatric patients undergoing staged cardiac reconstruction for cyanotic congenital heart disease

  2020cites this paper
• Anesthesia for Noncardiac Surgery in Children With Congenital Heart Disease

  2019cites this paper
• Cardiovascular Anesthesia for Adults with Congenital Heart Disease

  2019cites this paper
• Adult Congenital Heart Disease in Noncardiac Surgery

  2019cites this paper
• Serum Iron Status of Children with Cyanotic Congenital Heart Disease in Lagos, Nigeria

  2019cites this paper
• Factors associated with perioperative mortality in children and adolescents operated for tetralogy of Fallot: A sub‐Saharan experience

  2019cites this paper
• Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease

  2019cites this paper
• Arterial Thrombosis Secondary to Cardiac Catheterization in Neonates

  2019influential citation
• Cyanotic heart disease is an independent predicting factor for fresh frozen plasma and platelet transfusion after cardiac surgery.

  2019cites this paper
• Value of Rotational Thromboelastometry and Impedance Aggregometry for Evaluating Coagulation Disorders in Patients With Cyanotic and Nongenetic Congenital Heart Disease.

  2019cites this paper
• Coagulation Disorders in Congenital Heart Disease

  2019cites this paper
• Medications for Hemostasis

  2019cites this paper
• Comparison between Intravenous Boluses versus Infusion of Tranexamic Acid (TXA) to Reduce Bleeding in Paediatric Cyanotic Congenital Heart Disease (CHD) Surgeries.

  2018cites this paper
• Strategies for Prevention and Management of Bleeding Following Pediatric Cardiac Surgery on Cardiopulmonary Bypass: A Scoping Review

  2018cites this paper
• 11 – Late Repair and Reoperations in Adult Congenital Heart Disease

  2018cites this paper
• The Association Between Cyanosis and Thromboelastometry (ROTEM) in Children With Congenital Heart Defects: A Retrospective Cohort Study

  2017cites this paper
• Early experience with open heart surgery in a pioneer private hospital in West Africa: the Biket medical centre experience

  2017cites this paper
• Increased risk of thromboembolic events in adult congenital heart disease patients with atrial tachyarrhythmias.

  2017cites this paper
• Platelet count and mean platelet volume predict outcome in adults with Eisenmenger syndrome

  2017cites this paper
• The effects of corrective surgery on endothelial biomarkers and anthropometric data in children with congenital heart disease

  2017cites this paper
• Thrombo-hemorrhagic liability in children with congenital heart diseases.

  2017cites this paper
• Tetralogy of Fallot

  2017cites this paper
• Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients

  2017cites this paper
• Early Predictors of Thromboembolism in

  2017cites this paper
• Management of the Critically Ill Adult With Congenital Heart Disease.

  2017cites this paper
• Mathematical Analysis and Physical Profile of Blalock-Taussig Shunt and Sano Modification Procedure in Hypoplastic Left Heart Syndrome: Review of the Literature and Implications for the Anesthesiologist

  2017cites this paper
• The Coagulative Profile of Cyanotic Children Undergoing Cardiac Surgery: The Role of Whole Blood Preoperative Thromboelastometry on Postoperative Transfusion Requirement.

  2016cites this paper
• An evaluation of bilateral cerebral oxygen saturation during cyanotic and non-cyanotic cardiac surgery

  2016cites this paper
• Predictive Value of Intraoperative Thromboelastometry for the Risk of Perioperative Excessive Blood Loss in Infants and Children Undergoing Congenital Cardiac Surgery: A Retrospective Analysis.

  2016cites this paper
• Assessment of coagulation profile by thromboelastometry in adult patients with cyanotic congenital heart disease.

  2016influential citation
• Reference Intervals of Thromboelastometric Evaluation of Coagulation in Pediatric Patients with Congenital Heart Diseases: A Retrospective Investigation

  2016cites this paper
• Perioperative Management of a Child with Hypoplastic Left Heart Syndrome of the Jehovah's Witness Faith Presenting for Hybrid Comprehensive Stage II Procedure.

  2016cites this paper
• E-CHALLENGES & CLINICAL DECISIONS

  2015cites this paper
• Uncorrected Tetralogy of Fallot, Biventricular Dysfunction, and a Large Pericardial Effusion.

  2015cites this paper
• Anesthesia for cardiac surgery in neonates

  2015cites this paper
• Anästhesie bei Kindern und Jugendlichen nach angeborenen Herzfehlern

  2015cites this paper
• Anesthetic management of total tetralogy of Fallot repair in an adult patient after diagnosis by transesophageal echocardiography.

  2015cites this paper
• Role of thrombophilia factors in acute systemic–pulmonary shunt obstruction

  2015cites this paper
• Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.

  2015cites this paper
• Cyanotic congenital heart disease (CCHD): focus on hypoxemia, secondary erythrocytosis, and coagulation alterations

  2015cites this paper
• Modified Ultrafiltration During Cardiopulmonary Bypass and Postoperative Course of Pediatric Cardiac Surgery

  2014cites this paper
• Inflammatory Cytokines, Apoptotic, Tissue Injury and Remodeling Biomarkers in Children with Congenital Heart Disease

  2014cites this paper
• The influence of cardiopulmonary bypass priming without FFP on postoperative coagulation and recovery in pediatric patients with cyanotic congenital heart disease

  2014cites this paper
• Multivariate model for predicting postoperative blood loss in children undergoing cardiac surgery: a preliminary study.

  2014cites this paper
• Factors affecting postoperative blood loss in children undergoing cardiac surgery

  2014cites this paper
• Noninvasive treatment choice for an aged down syndrome patient presenting a residual periapical cyst.

  2014cites this paper
• Proteomic study reveals plasma protein changes in congenital heart diseases.

  2014cites this paper
• Validation of the megakaryocyte fragmentation theory of finger clubbing in patients with cardiopulmonary diseases

  2014cites this paper
• Role of Thrombophilic Mutations in Childhood Cardiac and Great Vessel Thrombosis

  2014cites this paper
• A prospective randomized controlled study to assess the efficacy of aprotinin in paediatric cardiac surgery

  2014cites this paper
• Anesthetic Considerations for Children with Congenital Heart Disease Undergoing Non-cardiac Surgery 41

  2014cites this paper
• COAGULATION ABNORMALITIES IN PEDIATRIC PATIENTS WITH CONGENITAL HEART DISEASE: A LITERATURE REVIEW

  2014influential citation
• 5 – Cardiovascular medicine

  2014cites this paper
• Intensivmedizinische Behandlung von Erwachsenen mit angeborenen Herzfehlern

  2013cites this paper
• Bleeding and Clotting in Children with Cardiac Disease

  2013cites this paper
• Case 6-2013: Perioperative management of an adult patient with tetralogy of fallot and pheochromocytoma.

  2013cites this paper
• Extra cardiac Fontan without cardiopulmonary bypass: techniques and early results

  2013cites this paper
• The haematocrit--an important factor causing impaired haemostasis in patients with cyanotic congenital heart disease.

  2013cites this paper
• Fibrinogen function is impaired in whole blood from patients with cyanotic congenital heart disease.

  2013cites this paper
• Management of Pediatric Cardiopulmonary Bypass

  2013cites this paper
• Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety.

  2013cites this paper
• Thrombolysis With Recombinant Tissue Plasminogen Activator in 7 Children

  2013cites this paper
• Approach to a Child with Bleeding in the Emergency Room

  2013cites this paper
• Ex-vivo response to blood products and haemostatic agents after paediatric cardiac surgery

  2013cites this paper
• Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association.

  2013cites this paper
• Tetralogy of Fallot

  2012cites this paper
• Bleeding and Thrombotic Emergencies in Pediatric Cardiac Intensive Care

  2012cites this paper
• Heparin brand is associated with postsurgical outcomes in children undergoing cardiac surgery.

  2012cites this paper
• Quantity without quality? Don't dismiss the value of platelet function testing quite yet.

  2012cites this paper
• Adults with Congenital Heart Disease

  2011cites this paper
• Noncardiac surgery in adult congenital heart disease

  2011cites this paper
• Adult congenital heart disease

  2011cites this paper
• Surgical Evaluation of Congenital-Heart-Disease-Associated Pulmonary Hypertension

  2011cites this paper
• CHAPTER 21 – Congenital Cardiac Anesthesia: Non-Bypass Procedures

  2011cites this paper
• 10 – Late Repair and Reoperations in Adults with Congenital Heart Disease

  2011cites this paper